R-MTX-zanbrutinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-MTX-zanbrutinib, covering 2022-05-31 to 2022-05-31. Get the full timeline:
Most recent: Clinical Trial Update: R-MTX-zanbrutinib in Secondary CNS Lymphoma [Phase 2]